Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study-Reference-Cited by-同舟云学术

Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study

Published:2019-07-15 Issue:14 Volume:58 Page:1993-2002
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yamao Kentaro¹,Takenaka Mamoru¹,Yoshikawa Tomoe¹,Ishikawa Rei¹,Okamoto Ayana¹,Yamazaki Tomohiro¹,Nakai Atsushi¹,Omoto Shunsuke¹,Kamata Ken¹,Minaga Kosuke¹,Hagiwara Satoru¹,Sakurai Toshiharu¹,Nishida Naoshi¹,Chiba Yasutaka²,Watanabe Tomohiro¹,Kudo Masatoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan

2. Clinical Research Center, Kindai University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/14/58_2234-18/_pdf

Reference49 articles.

1. 1. Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 41: 985-992, 2012.

2. 2. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364: 1817-1825, 2011.

3. 3. National Cancer Institute Common Terminology Criteria for Adverse Events v. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf

4. 4. Okusaka T, Ikeda M, Fukutomi A, et al. Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Sci 105: 1321-1326, 2014.

5. 5. Chllamma MK, Cook N, Dhani NC, et al. FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. Br J Cancer 115: 649-654, 2016.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Prophylactic Efficacy of Eflapegrastim and Pegteograstim for Chemotherapy-induced Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX/mFOLFIRINOX;Journal of Korean Society of Health-System Pharmacists;2024-08-31

2. Irinotecan dosing and pharmacogenomics: a comprehensive exploration based on UGT1A1 variants and emerging insights;Journal of Chemotherapy;2024-05-06

3. Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients;Cancers;2023-08-31

4. Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer;Anticancer Research;2022-12

5. FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study;Future Oncology;2022-07